Hospital or health organisation · founded 2002
Cleveland Clinic Lerner College of Medicine
Cleveland, United States · my.clevelandclinic.org/lerner-college-medicine
Part of Cleveland Clinic
- Citations, last 5 years
- 53.8k
- Works, last 5 years
- 5 304
- h-index
- 358
- Scientists listed
- 96
- Grants since 2016
- 2 258
Grants received
2024–2029 · research · R01
The vital role of T403 phosphorylation of STAT2 in post-viral bacterial pneumonia
Yuxin Wang · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2028 · research · R01
The Interplay between Genetics and Aerobic Exercise to Slow Parkinson's disease (GEARS) Trial
Jay L. Alberts · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · research · R01
Studying alcohol-associated liver disease and its interaction with rs738409 variant in PNPLA3 in a liver culture model
Xianfang Wu · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · career development · K01
Developing shared medical appointments for informal caregivers of Alzheimer’s and Dementia patients to improve knowledge, communication, and advanced planning
Jordan M Alpert · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2026 · fellowship · F32
The role of retrotransposonable elements in neurodevelopment and disease
Mary Talley · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2026 · research · R21
Forging a new path with cyclin-dependent kinase inhibitors to treat epithelioid hemangioendothelioma
Ajaybabu Pobbati · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · cooperative agreement · U01
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study
Jae U Jung · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · research · R01
The I-SCORE (Intensive Stroke Cycling for Optimal Recovery and Economic value) Trial
Susan Marie Linder · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2026 · research · R61
Development of a first-in-class complement inhibitor for treating complement-mediated hematologic diseases
Feng C Lin · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2028 · research · R01
Actin methylation as a novel mechanism that regulates gut barrier integrity and repair
Andrei Ivanovich Ivanov · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2028 · research · R01
Nutrition, terminal NAD metabolites and cardiovascular disease
Stanley L Hazen · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2026 · research · R21
Investigation of discrete neurodegenerative changes of the in vivo multiple sclerosis spinal cord using 7T MRI
Kedar Mahajan · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2026 · cooperative agreement · U01
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling
Andriy Marusyk · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2027 · research · R01
Gut microbial dietary phenylalanine metabolism and heart failure
Stanley L Hazen · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2027 · fellowship · F31
Characterizing the role of mitochondrial DNA mutations on retinal degeneration.
Johnathon Brian Sturgis · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2026 · research · R03
Connexin 43 drives glioblastoma cancer stem cells through a WNK1 signaling axis
Erin E. Mulkearns-Hubert · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2025 · research · R01
Supplement - Discovering the role of YES1 in triple negative breast cancer
Ruth A. Keri · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024 · research · R01
Transcriptional regulation of Myelopoiesis
Jayati Basu · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2026 · fellowship · F31
Ribonucleotide Reductase as a Driver of Breast Cancer Aggressiveness
Taylor Lynn Brzozowski · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2026 · research · R21
Modulation of Monocyte and T Cell Functions by Immune Inhibitory Receptors during Subclinical Malaria
Celia Dechavanne · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · career development · K01
Analysis of C9ORF72-associated poly (GR) interactions on BAF chromatin remodeling complex structure and function
Rodrigo Lopez Gonzalez · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · research · R01
Calcium imaging-based insights and guidance of deep brain stimulation to enhance chronic, post-stroke rehabilitation in a rodent model of ischemia
Kenneth B Baker · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2028 · research · R01
Actin methylation as a novel mechanism that regulates gut barrier integrity and repair
Andrei Ivanovich Ivanov · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · research · R01
Lymphatic dysfunction in neurodevelopmental disorders and associated behaviors
Antoine Louveau · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2027 · fellowship · F31
Characterizing the role of mitochondrial DNA mutations on retinal degeneration.
Johnathon Brian Sturgis · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2027 · research · R13
Clinical Scholars Career Development Program (CSCDP)
Kurt Paul Spindler · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2026 · research · R37
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer
Jacob Gardinier Scott · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · research · R01
KSHV-mediated metabolic reprogramming for LANA expression and viral persistency
Jae U Jung · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · career development · K25
Use of gold-based photothermal nanomaterials for the comminution of kidney stones
Ian Houlihan · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2030 · cooperative agreement · UH3
1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
Gustavo Adolfo Heresi Davila · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · research · R01
The I-SCORE (Intensive Stroke Cycling for Optimal Recovery and Economic value) Trial
Susan Marie Linder · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2026 · research · R21
Targeting NEK2 to potentiate standard of care therapies for breast cancer
Ruth A. Keri · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2028 · research · R01
Nutrition, terminal NAD metabolites and cardiovascular disease
Stanley L Hazen · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · research · R01
The vital role of T403 phosphorylation of STAT2 in post-viral bacterial pneumonia
Yuxin Wang · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2028 · research · R01
The Interplay between Genetics and Aerobic Exercise to Slow Parkinson's disease (GEARS) Trial
Jay L. Alberts · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · research · R01
Studying alcohol-associated liver disease and its interaction with rs738409 variant in PNPLA3 in a liver culture model
Xianfang Wu · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2028 · research · R01
Molecular mechanism of Zika virus-induced premature craniofacial suture closure
Weiqiang Chen · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2027 · research · R00
Modifiable Determinants of Disparities in Multiple Myeloma Treatment Patterns
Hamlet Gasoyan · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2027 · research · R01
Gut microbial dietary phenylalanine metabolism and heart failure
Stanley L Hazen · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
2024–2029 · career development · K23
Leukotriene B4 and IL-8 in alpha-1 heterozygotes (PI*MZ genotype)
Vickram Tejwani · Cleveland Clinic Lerner College of Medicine · funded by National Institutes of Health
